About Ferium Injection 500 mg/10 ml
Ferium Injection is made by Renata PLC. It contains Ferric Carboxymaltose 500 mg/10 ml and comes as an injection. It is a parenteral iron preparation given by a healthcare professional to treat iron deficiency anemia in certain adults.
There are 15 brands of Ferric Carboxymaltose listed in Bangladesh. By unit price, Ferium Injection is among the cheapest of them.
What is Ferium Injection 500 mg/10 ml?
Ferium Injection from Renata PLC contains Ferric Carboxymaltose 500 mg/10 ml in injection form. It belongs to the parenteral iron preparations, meaning iron is given into the body rather than by mouth. It is used for iron deficiency anemia in adults who cannot tolerate oral iron or who have not responded well to it, and in adults with non-dialysis dependent chronic kidney disease. Because it is given by injection, it is handled by trained healthcare staff who can watch for reactions during and after administration.
Uses of Ferium Injection
Ferium Injection is used to treat iron deficiency anemia in adults. It is intended for people who do not tolerate iron taken by mouth or who have not had a satisfactory response to oral iron. It is also used in adults with non-dialysis dependent chronic kidney disease. The iron in the injection helps replace the body's iron stores. Ask the doctor whether this treatment suits your situation.
How to use Ferium Injection
Ferium Injection is given by a healthcare professional; it is not for self-administration. The doctor decides the dose and course, taking into account the person's weight and needs. It is usually given as more than one dose with time between doses, and treatment may be repeated if the anemia comes back. Staff watch the person during and after the injection for any reactions. Follow the doctor's instructions about follow-up.
Side effects of Ferium Injection
Some people may have nausea, vomiting, dizziness, headache, flushing, high or low blood pressure, constipation, itching, rash, hives, wheezing, a bad taste, raised liver enzyme results, decreased blood phosphorus, or discoloration at the injection site. Serious allergic-type reactions, some life-threatening, have been reported with this type of iron injection. Tell the healthcare staff at once if you feel unwell during or after the injection.
Safety and precautions
Ferium Injection must be given where staff and treatments for serious allergic reactions are available, and patients are monitored during and after administration. Do not receive it if you are allergic to any of its components. It is pregnancy category C, so pregnant women should ask the doctor about benefits and risks. People with other medical conditions, or those taking other medicines, should check with the doctor first. The doctor decides whether this treatment is appropriate.
Frequently asked questions
How should Ferium Injection be stored?
It should be kept below the upper temperature limit stated on the product information and must not be frozen. Storage and handling are usually managed by the hospital or clinic pharmacy, so ask them if you need details.
What is Ferium Injection used for and what kind of medicine is it?
It is a parenteral iron preparation, an iron injection. It treats iron deficiency anemia in adults who cannot tolerate oral iron or do not respond well to it, and in adults with non-dialysis dependent chronic kidney disease.
How is Ferium Injection taken?
It is given by a healthcare professional as an injection, not taken at home. The doctor decides the dose and the course based on your weight and needs. Ask the doctor or pharmacist about your schedule and follow-up.
Who should ask a doctor before receiving it?
Anyone with a known allergy to any component, pregnant women, and people with other medical conditions or other medicines should speak to the doctor first. The doctor will decide if this treatment is suitable for you.
- Strength
- 500 mg/10 ml
Price in Bangladesh
৳ 686 ৳ 700 2% off unit price
Price updated: 16 Nov 2026
Indications
Ferric Carboxymaltose is indicated for the treatment of iron deficiency anemia in adult patients-
- Who have intolerance to oral iron or have had unsatisfactory response to oral iron
- Who have non-dialysis dependent chronic kidney disease.
Pharmacology
Non-dextran, IV is a colloidal iron hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron; replaces iron stores found in hemoglobin, myoglobin, and enzymes; works to transport oxygen via hemoglobin Macrophage engulf FCM from blood and control iron release. Transferrin saturates and, Iron into the liver, spleen and Bone marrow.
Dosage & Administration
For patients weighing 50 kg or more: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 750 mg for a total cumulative dose not to exceed 1500 mg of iron per course.
For patients weighing less than 50 kg: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 15 mg/kg body weight for a total cumulative dose not to exceed 1500 mg of iron per course.
The dosage of Ferric Carboxymaltose is expressed in mg of elemental iron. Each mL of Ferric Carboxymaltose contains 50 mg of elemental iron. Ferric Carboxymaltose treatment may be repeated if iron deficiency anemia reoccurs.
Administer Ferric Carboxymaltose intravenously, either as an undiluted slow intravenous push or by infusion. When administering as a slow intravenous push, give at the rate of approximately 100 mg (2 mL) per minute. When administered via infusion, dilute up to 750 mg of iron in no more than 250 mL of sterile 0.9% sodium chloride injection, USP, such that the concentration of the infusion is not less than 2 mg of iron per mL and administer over at least 15 minutes.
When added to an infusion bag containing 0.9% Sodium Chloride Injection, USP, at concentrations ranging from 2 mg to 4 mg of iron per mL, Ferric Carboxymaltose solution is physically and chemically stable for 72 hours when stored at room temperature. To maintain stability, do not dilute to concentrations less than 2 mg iron/mL.
Inspect parenteral drug products visually for the absence of particulate matter and discoloration prior to administration. The product contains no preservatives. Each vial of Ferric Carboxymaltose is intended for single use only. Any unused drug remaining after injection must be discarded.
Avoid extravasation of Ferric Carboxymaltose since brown discoloration of the extravasation site may be long lasting. Monitor for extravasation. If extravasation occurs, discontinue the Ferric Carboxymaltose administration at that site.
Interaction
There are no known drug interactions and none well documented.
Contraindications
Hypersensitivity to any of its components.
Side Effects
Nausea, Hypertension, Flushing, Decreased blood phosphorus, Dizziness, Vomiting, Pruritus, Rash, Urticaria, Wheezing, Injection site discoloration, Headache, Increased alanine aminotransferase), Dysgeusia, Hypotension, Constipation, Serious anaphylactic/anaphylactoid reactions
Pregnancy & Lactation
Pregnancy Category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks
Precautions & Warnings
Hypersensitivity Reactions: Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Ferric carboxymaltose. Patients may present with shock, clinically significant hypotension, loss of consciousness, and/or collapse. Monitor patients for signs and symptoms of hypersensitivity during and after Ferric carboxymaltose administration for at least 30 minutes and until clinically stable following completion of the infusion. Only administer Ferric carboxymaltose when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions. Other serious or severe adverse reactions potentially associated with hypersensitivity which included, but not limited to, pruritus, rash, urticaria, wheezing, or hypotension may occur.
Hypertension: Transient elevations in systolic blood pressure, sometimes occurring with facial flushing, dizziness, or nausea were observed. These elevations generally occurred immediately after dosing and resolved within 30 minutes. Monitor patients for signs and symptoms of hypertension following each Ferric carboxymaltose administration.
Storage Conditions
Do not store above 30°C. Do not freeze.
Alternative brands of Ferric Carboxymaltose
Other brands with the same generic name, cheapest first.
See all 15 brands
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.